Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Maternal HIV: Trial to Assist Disclosure to Children (TRACK II)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by Lisa Armistead, Georgia State University
University of California, Los Angeles
Information provided by (Responsible Party):
Lisa Armistead, Georgia State University Identifier:
First received: August 2, 2013
Last updated: May 19, 2016
Last verified: February 2016

August 2, 2013
May 19, 2016
March 2013
April 2017   (Final data collection date for primary outcome measure)
Disclosure of Maternal HIV status to child [ Time Frame: Change in disclosure status between time points 3-, 9-, & 15 month follow ups ]
Same as current
Complete list of historical versions of study NCT01922206 on Archive Site
Child Mental Health Functioning (Composite measure) [ Time Frame: 15- month follow up ]
Self and Caregiver reported indicators, including the Child Depression Inventory, Piers-Harris Children's Self-Concept Scale, Penn State Worry Questionnaire
Same as current
  • Maternal Functioning (composite measure) [ Time Frame: 15 month follow-up ]
    CES-D, GAD-7, Health-Related Anxiety Questionnaire, Medical Outcomes Study-Health Self-Report, Alcohol and Drug Assessment
  • Family functioning (composite measure) [ Time Frame: 15 month follow-up ]
    Cohesiveness, routines, parent-child communication, parent-child relationship quality
Same as current
Maternal HIV: Trial to Assist Disclosure to Children
2/2-Maternal HIV: Multisite Trial to Assist Disclosure to Children

The purpose of this Collaborative R01, under Program Announcement PAR-09-153, is to conduct a full-scale trial of an intervention to assist mothers living with HIV (MLH) with disclosing their serostatus to their young age 6 - 14 year old), well children. A pilot study of the intervention has recently been completed (R01 MH077493) and met its major aims. The basis for development of the pilot intervention was work from three R01s (MH057207, currently Yr. 14) designed to longitudinally assess MLH and their children. Within that work, several studies were conducted on maternal disclosure, suggesting disclosure is difficult, and outcomes for MLH and children could be improved by intervention. The pilot study, known in the community as Teaching, Raising, And Communicating with Kids (TRACK), was based on integrative disclosure theory. Results of the pilot trial indicate that those in the intervention group were six times more likely to disclose their HIV/AIDS status to their child than those in the control group (O.R. 6.33); by the 9-month follow-up 33% of intervention MLH disclosed, compared to only 7.3% of the control group. Perhaps more importantly, the intervention group's emotional functioning and their satisfaction improved significantly following the intervention, compared to the control group. Similarly, child mental health indicators among children of intervention MLH were significantly better than control group children at follow-ups. In this study, TRACK II, we propose to conduct a full-scale trial of the intervention in two sites: (1) Los Angeles county (Site 1, where the pilot trial was conducted), which will include a high proportion of Latina families and a smaller proportion of African-American and White families; and (2) Atlanta, Georgia (Site 2, where the primary consultant on the pilot trial conducts research), which will include a high proportion of Southern African-American families, as well as White families. MLH and their children (N = 440 total; 110 mothers and 110 children per site, n = 220 per site) will be assessed at baseline and at 3, 9, and 15-month follow-ups. MLH will be randomly assigned to the intervention or control. Aims are to:

  1. facilitate disclosure of the mothers' HIV status to the children, which will include secondary aims of:

    1. increasing mothers' self-efficacy to disclose and respond to child questions regarding HIV;
    2. reducing mothers' fears regarding disclosure and stigma;
    3. improving maternal knowledge of child development and how to provide appropriate levels of information given the age of the child;
  2. improve MLH mental health indicators over time (i.e., depression, anxiety, quality of life);
  3. improve child mental health indicators over time (i.e., depression, anxiety, acting out behaviors); and
  4. improve family functioning indicators (e.g., cohesion, perceived closeness between mother and child).
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Behavioral: TRACK Intervention

TRACK Intervention

3-session, individually administered psycho-educational intervention to promote maternal disclosure of HIV status to child

  • No Intervention: Wait-list Control
    Participants in the wait-list control condition will receive a group-based version of the TRACK intervention after their 15-month follow up appointment.
  • Experimental: TRACK Intervention
    3-session, individually administered psycho-educational intervention to promote maternal disclosure of HIV status to child
    Intervention: Behavioral: TRACK Intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
April 2017
April 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Mother is HIV+
  • ability of mother and child to speak and understand English or Spanish
  • child is not HIV+
  • Child is 6-14 years old
  • Child is unaware of maternal HIV status
  • child resides with mother

Exclusion Criteria:

  • Mother does not consent
  • Child does not assent
  • Psychosis of mother or child
  • Child diagnosed with depression
  • child is developmentally delayed
  • Recent or anticipated death in the family
Sexes Eligible for Study: All
Child, Adult, Senior
Contact: Lisa P Armistead, Ph.D. 404 413 6205
Contact: Debra Murphy, Ph.D. 310 267-5233
United States
1R01MH094233 ( US NIH Grant/Contract Award Number )
Not Provided
Data sharing protocols for the longitudinal data from 220 young children and 220 mothers will be in accordance with NIH Notice of Amendment to A-110, consistent with IRB-approved consent restrictions, and follow Inter-University Consortium for Political and Social Research guidelines for data preparation. Data will be stripped of identifiers and available under signed agreement for: (1) using data only for research; (2) securing date using appropriate technology; and (3) destroying or returning data after analyses. Notice of available data will be on both centers' websites, with data use restrictions.
Lisa Armistead, Georgia State University
Georgia State University
University of California, Los Angeles
Principal Investigator: Lisa P Armistead, Ph.D. Georgia State University
Principal Investigator: Debra Murphy, Ph.D. University of California, Los Angeles
Georgia State University
February 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP